• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Varian and Siemens launch global radiosurgery deal | Wall Street Beat

Varian and Siemens launch global radiosurgery deal | Wall Street Beat

April 26, 2012 By MassDevice staff

MassDevice.com Wall Street Beat

 Varian and Siemens sign global radiosurgery collaboration deal
Varian Medical (NYSE:VAR) and Siemens (NYSE:SI) signed a global collaboration agreement to jointly pursue diagnostic and therapeutics solutions in image-guided radiosurgery and radiotherapy.

The deal includes mutual marketing worldwide for radiation oncology systems, software development between Siemens’ and Varian’s systems and exploration of opportunities for joint development of new products.

The news comes as rival radiosurgery devices maker Accuray launched a clinical study pitting its CyberKnife system against surgical prostatectomy with Intuitive Surgical’s (NSDQ:ISRG) da Vinci surgical robot in efforts to establish a new gold standard in treating early-stage prostate cancer.
Read more

 Bausch & Lomb eyes new devices
Troubled eye-care giant Bausch & Lomb is looking toward medical devices, including a new cataract surgery system up for FDA approval, as it aims to put aside a slew of recalls and reposition itself in the market.
Read more

 Keir Surgical signs exclusive distribution with Viking Systems
Viking Systems (OTC:VKNG) signed a deal making Keir Surgical the exclusive Canadian distributor for its products, including the Viking 3DHD Vision Systems  
Read more

 Fluoptics lands in Cambridge, Mass.

French fluorescence image-guided surgery devices maker Fluoptics opened a sales & marketing office in Cambridge, Mass.
 
Read more

 NxStage CEO Burbank sheds 9.2k shares
NxStage Medical (NSDQ:NXTM) president & CEO exercised his right to purchase 9,250 NXTM shares at $8.55 apiece, selling them for $16.93 each for a total gain of more than $77,500, according to SEC filings.
Read more

 Baxter finalizes buyout of Sigma
Baxter (NYSE:BAX) bought up the remaining 60% of Sigma International for about $90 million in cash.  
Read more

 Funding Roundup

  • Hamilton Thorne offers Canadian private placement of up to $750,000
  • PhotoMedex prices $40M public offering at $13.32 per share
  • Innovacell announces lands $11M to support Phase III studies
  • Forus Health lands $5M investment for portable ophthalmology pre-screener
  • Cadence Biomedical touts over-subscribed $1.1M Series A2 funding round

 Analysts’ ups and downs

  • Amgen (NSDQ:AMGN): UBS raises estimates and gives "neutral" rating as shares approach $71 on top of positive quarterly results
  • HeartWare International‘s (NSDQ:HTWR): Leerink Swann rates "outperform" with a $95 valuation.
  • Palomar Medical (NSDQ:PMTI): Cannaccord Genuity maintains "buy" rating; Leerink Swann maintains "market perform" rating
  • Varian Medical (NYSE:VAR): Citigroup lowers to "neutral" rating, sets price target at $67; Jeffries lower price target from $75 to $73, maintains "overweight" rating
  • Zimmer (NYSE:ZMH): Leerink Swann maintains "market perform" rating

Filed Under: Funding Roundup, News Well, Optical/Ophthalmic, Radiosurgery/Radiation therapy, Wall Street Beat Tagged With: Amgen, Bausch + Lomb, Baxter, Cadence Biomedical, Fluoptics, Forus Health, Hamilton Thorne Inc., HeartWare International Inc., Innovacell, Keir Surgical, NxStage Medical Inc., Palomar Medical Technologies Inc., PhotoMedex Inc., Siemens, Varian Medical Systems, Viking Systems Inc., Zimmer Biomet

In case you missed it

  • Orchestra BioMed to go public, partner with Medtronic on cardiac neuromodulation therapy
  • Memic Innovative Surgery is now Momentis Surgical
  • Lyra Therapeutics appoints new chief medical officer
  • Masimo’s SafetyNet monitoring reduced length of COVID-19 hospital stays, study says
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • Enovis partners with Kelvi on hot and cold therapies
  • West Pharmaceutical Services debuts new needle syringe system
  • Titan Medical names Cary G. Vance as new president, CEO
  • Acutus completes first closing in left-heart access portfolio sale to Medtronic
  • FDA clears Intuitive, Siemens Healthineers imaging integration for robotic bronchoscopy
  • FDA backs COVID-19 boosters with BA.4/5 spike proteins for fall
  • How safe is health information after the overturning of Roe?
  • Smith+Nephew opens new plant in Malaysia
  • BD launches combination COVID-19, flu, RSV diagnostic test
  • Zimmer Biomet creates independent nonprofit organization to reduce health disparities
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge

RSS From Medical Design & Outsourcing

  • DeviceTalks Boston 2022: Here’s what you missed on the show floor
    At DeviceTalks Boston 2022, there was a wealth of expertise to be had from exhibitors including Viant, ICS, PSN Labs, Propel and more. From stories of overcoming challenges during the COVID-19 pandemic to medical device materials pitfalls to avoid, MassDevice and MDO executive editor Chris Newmarker hit the DeviceTalks Boston show floor to discover insights. […]
  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
  • Philips updates on testing results for recalled ventilators
    Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS